GeneDx Holdings Corp.

GeneDx Holdings Corp., listed under ticker CMLF, originated as CM Life Sciences III Inc., a blank-check company that completed its initial public offering in 2020 with a focus on the healthcare and life sciences sector. Sponsored by CM Life Sciences III LLC, an affiliate of Casdin Capital, the vehicle filed this Form 10-Q with the SEC on November 16, 2020, covering an early reporting period following its IPO while still searching for a business combination target. The SPAC subsequently merged with Sema4, a genomic health intelligence company, and the combined entity later acquired GeneDx from OPKO Health before adopting the GeneDx Holdings Corp. name. For complete filing histories, sponsor profiles, and deal timelines on CMLF and thousands of other SPACs, sign up for full data access at SpacDesk.